Wolters Kluwer Health has entered a joint venture with Medicom to enhance clinical decision support services in China's evolving healthcare market.

Target Information

Wolters Kluwer Health has entered into a joint venture with Medicom, a prominent drug information provider based in Chengdu, Sichuan Province, China. This strategic partnership aims to enhance clinical decision support (CDS) services for healthcare professionals in China as the country undergoes significant reforms in its healthcare system. By leveraging Medicom’s established presence and expertise in drug information, the collaboration seeks to expand Wolters Kluwer’s market-leading CDS and drug information offerings within the rapidly evolving healthcare landscape of China.

Medicom is well-positioned within the Chinese healthcare market, providing essential drug information and services that are critical for doctors, pharmacists, and hospitals. The integration of Medicom's products with Wolters Kluwer Health’s Clinical Solutions business will create an extensive library of clinical content, enabling healthcare professionals to access vital evidence-based medical information at the point of care and during their learning processes.

Industry Overview

The Chinese healthcare industry is at a pivotal moment, marked by ongoing reforms aimed at improving healthcare delivery and establishing standardized care practices. These reforms have resulted in an increasing demand for clinical decision support to